Apotex recalls hypertension capsules that may be empty; Tobacco gets bioengineered;

> Apotex, is voluntarily recalling Lot JR2178 of hypertension drug Apo-Ramipril 5-mg capsules because some of the capsules are empty. Story

> Inserogen, a startup formed by a Ph.D. from the Universtiy of California-Davis, intends to use its "SwiftVax" plants to turn tobacco into cheap biological factories for bioengineered proteins. Story

> A survey of U.S. and EU pharmaceutical executives found a significant number who believe that "the business model is broken" and needs to be addressed by redeploying resources. Release

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.